Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab von Blauvelt, Andrew, Pink, Andrew, Worm, Margitta, Langley, Richard G. B, Elewski, Boni E, Gjerum, Le, Guttman-Yassky, Emma

Volltext

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis von Langley, Richard G. B., Reich, Kristian, Strand, Vibeke, Feldman, Steven R., Paul, Carle, Gordon, Kenneth, Warren, Richard B., Toth, Darryl, Nikaï, Enkeleida, Zhu, Baojin, Goldblum, Orin, Edson-Heredia, Emily, Carlier, Hilde, Burge, Russel, Lin, Chen-Yen, Hollister, Kristin, Augustin, Matthias

Volltext

No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis von Strober, B.E., Langley, R.G.B., Menter, A., Magid, M., Porter, B., Fox, T., Safi, J., Papavassilis, C.

Volltext

Psoriasis: epidemiology, clinical features, and quality of life von Langley, R G B, Krueger, G G, Griffiths, C E M

Volltext

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and S... von Papp, Kim, MD, PhD, Reich, Kristian, MD, PhD, Leonardi, Craig L., MD, Kircik, Leon, MD, Chimenti, Sergio, MD, Langley, Richard G.B., MD, Hu, ChiaChi, EdM, MS, Stevens, Randall M., MD, Day, Robert M., PhD, Gordon, Kenneth B., MD, Korman, Neil J., MD, PhD, Griffiths, Christopher E.M., MD, FMedSci

Volltext

A Review of Malignancies Observed during Efalizumab (Raptiva®) Clinical Trials for Plaque Psoriasis von Leonardi, Craig L., Toth, Darryl, Cather, Jennifer C., Langley, Richard G.B., Werther, Winifred, Compton, Peter, Kwon, Paul, Wetherill, Graham, Curtin, Francois, Menter, Alan

Volltext

Calcipotriol plus Betamethasone Dipropionate Gel Compared with Tacalcitol Ointment and the Gel Vehicle Alone in Patients with Psoriasis Vulgaris: A Randomized, Controlled Clinical... von Langley, Richard G.B., Gupta, Aditya, Papp, Kim, Wexler, Denise, Østerdal, Marie Louise, Çurčić, Dušica

Volltext

Mycosis Fungoides Presenting as Pigmented Purpuric Dermatitis von Hanna, Shannon, Walsh, Noreen, D'Intino, Yolanda, Langley, Richard G. B.

Volltext

The Diagnostic Accuracy of in vivo Confocal Scanning Laser Microscopy Compared to Dermoscopy of Benign and Malignant Melanocytic Lesions: A Prospective Study von Langley, Richard G.B., Walsh, Noreen, Sutherland, Ashley E., Propperova, Iva, Delaney, Laura, Morris, Steven F., Gallant, Christopher

Volltext

Academic branding: erythema ab igne and use of laptop computers von Botten, David, Langley, Richard G B, Webb, Amanda

Volltext

Secukinumab re‐initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis von Blauvelt, A., Reich, K., Warren, R.B., Szepietowski, J.C., Sigurgeirsson, B., Tyring, S. K., Messina, I., Bhosekar, V., Oliver, J., Papavassilis, C., Frueh, J., Langley, R.G.B.

Volltext

Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease von Shear, Neil H., Prinz, Jörg, Papp, Kim, Langley, Richard G.B., Gulliver, Wayne P.

Volltext

Agminated Segmental Nevi Demonstrating Intranevic Concordance of BRAF Status von Luo, Su, Chaplin, Anna C., Langley, Richard G.B., Njauw, Ching-Ni, Duncan, Lyn M., Miller, Robert A., Tsao, Hensin

Volltext

Sustained Efficacy and Safety of Pimecrolimus Cream 1% when Used Long-term (up to 26 Weeks) to Treat Children with Atopic Dermatitis von Langley, Richard G. B., Eichenfield, Lawrence F., Lucky, Anne W., Boguniewicz, Mark, Barbier, Nathalie, Cherill, Robert

Volltext

In vivo confocal scanning laser microscopy of benign lentigines: Comparison to conventional histology and in vivo characteristics of lentigo maligna von Langley, Richard G.B., Burton, Elizabeth, Walsh, Noreen, Propperova, Iva, Murray, Scott J.

Volltext

An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing Surveillance von Langley, Richard G.B., Luger, Thomas A., Cork, Michael J., Schneider, Dirk, Paul, Carle

Volltext

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents von Eichenfield, Lawrence F., Lucky, Anne W., Boguniewiczc, Mark, Langley, Richard G.B., Cherille, Robert, Marshalle, Katharine, Bushe, Christopher, Graeber, Michael

Volltext

Use of pimecrolimus cream 1% (Elidel®) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcom... von Eichenfield, Lawrence F., Lucky, Anne W., Langley, Richard G. B., Lynde, Charles, Kaufmann, Roland, Todd, Gail, Lindsley, Linda, Barbier, Nathalie, Felser, James M.

Volltext

Erdheim-Chester Disease of the Breast: A Case Report and Review of the Literature von Barnes, Penny J., Foyle, Annette, Haché, Kelly A. Dakin, Langley, Richard G. B., Burrell, Steven, Juskevicius, Ridas

Volltext

T-Cell Modulation for the Treatment of Chronic Plaque Psoriasis with Efalizumab (Raptiva™): Mechanisms of Action von Jullien, D., Prinz, J.C., Langley, R.G.B., Caro, I., Dummer, W., Joshi, A., Dedrick, R., Natta, P.

Volltext